Evidence map›Paper›PMID 31916131›Full record

ArticleCardiovascular drugs and therapy2019

Absence of Functional Na

Simona Casini, Gerard A Marchal, Makiri Kawasaki, Fransisca A Nariswari, Vincent Portero, Nicoline W E van den Berg, Kaomei Guan, Antoine H G Driessen, Marieke W Veldkamp, Isabella Mengarelli and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular drugs and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Blocking NaBMC cardiovascular disorders · 2024
    Article
  6. NaInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Review
  9. Patient-specific induced pluripotent stem cell properties implicate CaPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  10. Molecular and Functional Relevance of NaInternational journal of molecular sciences · 2023
    Article
  11. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  12. Article
  13. Review
  14. Injection of IFrontiers in physiology · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Blockade of NaFrontiers in cardiovascular medicine · 2021
    Article
  19. Article
  20. Role of Non-Coding Variants in Brugada Syndrome.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Simona CasiniDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands. s.casini@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-2672-2779
Gerard A MarchalDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Makiri KawasakiDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Fransisca A NariswariDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Vincent PorteroDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Nicoline W E van den BergDepartment of Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Kaomei GuanInstitute of Pharmacology and Toxicology, Technische Universität Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
Antoine H G DriessenDepartment of Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Marieke W VeldkampDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Isabella MengarelliDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Joris R de GrootDepartment of Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Arie O VerkerkDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Carol Ann RemmeDepartment of Experimental Cardiology, Amsterdam UMC, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands.
Amsterdam University Medical Centers · NLAmsterdam Neuroscience · NLTechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSeveral studies have indicated a potential role for SCN10A/Na

methodsThe effects of the Na

resultsA-803467 treatment caused a slight shortening of the action potential duration (APD) in rabbit CMs and hiPSC-CMs, while it had no effect on APD in human atrial cells. Resting membrane potential, action potential (AP) amplitude, and AP upstroke velocity were unaffected by A-803467 application. Similarly, I

conclusionWe here demonstrate the absence of functional Na

Indexed as

Action PotentialsAnimalsAtrial AppendageCell LineHeart VentriclesHumansInduced Pluripotent Stem CellsKineticsMaleMyocytes, CardiacNAV1.8 Voltage-Gated Sodium ChannelRabbitsSpecies SpecificityVoltage-Gated Sodium Channel BlockersNAV1.8 Voltage-Gated Sodium ChannelSCN10A protein, humanVoltage-Gated Sodium Channel BlockersCardiomyocyteshiPSC-CMsLate sodium currentPatch-clampSCN10A/Nav1.8Sodium channel

Identifiers

PMID31916131
PMCPMC6994555
OpenAlexW3000576873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.